Diagnostyka

Diagnostyka Current Assets

The Current Assets of Diagnostyka (DIA.WA) as of Nov 2, 2026 is 68.74 M PLN. In the previous year, Current Assets was 281.44 M PLN — a change of -75.58% (lower).

Current Assets

68.74 MPLN

YoY

-75.58%

Last updated:

Current Assets of Diagnostyka is 2025 68.74 M PLN. Current Assets of Diagnostyka was 2024 281.44 M PLN. It decreases by -75.58% lower compared to the previous year.

The Diagnostyka Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2021
259.00 M PLN
Jan 1, 2022
166.15 M PLN
Jan 1, 2023
214.70 M PLN
Jan 1, 2024
281.44 M PLN
Jan 1, 2025
68.74 M PLN
The Diagnostyka Current Assets history
YEARCurrent AssetsYoY
68.74 MPLN-75.58%
281.44 MPLN+31.09%
214.70 MPLN+29.22%
166.15 MPLN-35.85%
259.00 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diagnostyka Stock analysis

What does Diagnostyka do? Diagnostyka SA generates revenue through its network of 180 laboratories and 1,100 Sampling Labs across Poland, offering over 3,000 test types including hematology, infection diagnostics, allergology, and hormonal diagnostics. The company provides both routine and specialist laboratory services, with tests available with or without a physician's referral, catering to individual patients and healthcare providers. Its specialization in molecular biology, autoimmune diagnostics, and blood collection drives demand from private individuals seeking direct access to medical analysis without a doctor's prescription. The firm's revenue model relies on a comprehensive service chain from biological material collection and transportation to final analysis results, serving a broad customer base including patients, clinics, and hospitals. With a focus on accessible diagnostics, Diagnostyka SA expands its market reach through its extensive lab network, enabling widespread availability of medical testing services throughout Poland. The company's ability to deliver specialized tests like molecular biology and autoimmune diagnostics differentiates its offerings in the healthcare sector. Diagnostyka is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diagnostyka stock

Current Assets of Diagnostyka is 68.74 M PLN in 2025.

Current Assets of Diagnostyka changed from 281.44 M PLN to 68.74 M PLN, representing a -75.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Diagnostyka since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Diagnostyka historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Diagnostyka

All Key Metrics — Diagnostyka